Cycrin and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Cycrin (medroxyprogesterone acetate), especially for people who are female, 50-59 old, have been taking the drug for 10+ years also take Premarin, and have Menopause.

The phase IV clinical study analyzes which people have Fall when taking Cycrin. It is created by eHealthMe based on reports of 5,085 people who have side effects when taking Cycrin from the FDA, and is updated regularly.

What is Cycrin?

Cycrin has active ingredients of medroxyprogesterone acetate. eHealthMe is studying from 5,086 Cycrin users. Check the latest studies of Cycrin.

What is Fall?

Fall is found to be associated with 3,236 drugs and 3,760 conditions by eHealthMe. Check the latest studies of Fall.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

5,085 people reported to have side effects when taking Cycrin.
Among them, 33 people (0.65%) have Fall.

Among these 33 people:

How long have people been on Cycrin when they have Fall? *

What is the gender of people who have Fall when taking Cycrin? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Fall when taking Cycrin? *

What are other drugs people take besides Cycrin? *

Premarin: 24 people, 72.73%
Estraderm: 22 people, 66.67%
Provera: 18 people, 54.55%
Prempro: 16 people, 48.48%
Fosamax: 9 people, 27.27%
Prilosec: 8 people, 24.24%
Synthroid: 7 people, 21.21%
Medroxyprogesterone Acetate: 7 people, 21.21%
Ogen: 6 people, 18.18%
Prometrium: 6 people, 18.18%

What are other side effects people have besides Fall? *

Osteopenia (a condition where bone mineral density is lower than normal): 21 people, 63.64%
High Blood Pressure: 13 people, 39.39%
Osteoporosis (bones weak and more likely to break): 12 people, 36.36%
Breast Cancer: 12 people, 36.36%
Hot Flush (sudden feelings of heat): 11 people, 33.33%
Weakness: 10 people, 30.30%
Nausea (feeling of having an urge to vomit): 9 people, 27.27%
Pain: 9 people, 27.27%
Back Pain: 9 people, 27.27%
Headache (pain in head): 8 people, 24.24%

What are the existing conditions these people have? *

Menopausal Symptoms: 6 people, 18.18%
High Blood Cholesterol: 6 people, 18.18%
Menopause (end of monthly cycles in women): 6 people, 18.18%
Migraine (headache): 4 people, 12.12%
Osteoporosis (bones weak and more likely to break): 4 people, 12.12%
Diabetes: 4 people, 12.12%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 9.09%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 3 people, 9.09%
Depression: 2 people, 6.06%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Cycrin and have Fall?

- Check whether Fall is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cycrin:

Cycrin (5,086 reports)

Fall treatments and more:

Fall (403,513 reports)

Browse all side effects of Cycrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

Fall (3,236 drugs)

Browse all the conditions that are associated with Fall:

Fall (3,760 conditions)

Related publications that referenced our studies

Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on medroxyprogesterone acetate (the active ingredients of Cycrin) and Cycrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.